Nasdaq’s Hearings Panel issued a decision letter on December 9, 2025, and MMTEC announced the ruling on December 11, 2025. The panel placed the company under a one‑year monitoring period after finding that MMTEC’s stock had closed below the $1.00 bid‑price threshold for 30 consecutive business days, a violation that would have triggered a delisting notice on November 5, 2025.
The ruling reflects Nasdaq’s tightened rules on reverse stock splits. MMTEC’s one‑for‑eight reverse split on December 18, 2024, made the company ineligible for the standard 180‑day cure period that normally follows a bid‑price deficiency. The company had previously faced a similar non‑compliance notice in July 2024, underscoring a recurring challenge in maintaining the minimum bid price after a reverse split.
Financially, MMTEC reported first‑half 2025 revenue of $0.81 million, up from nil in the prior period, while its net loss widened due to credit‑loss provisions and the sale of notes receivable. The company’s operations are split between Gujia, which supplies market‑data and investor‑relations services, and MM Global, which focuses on broader financial‑market access. The low bid price has been driven by thin trading volume and the dilution effect of the reverse split, which compressed the share count and lowered the market price.
Under the one‑year panel monitor, MMTEC must demonstrate compliance with Nasdaq’s listing requirements or face a suspension of trading. The panel’s decision effectively suspends the immediate delisting that would have occurred on November 5, 2025, but it does not guarantee continued listing beyond the monitoring period. The outcome places a significant compliance deadline on the company and limits its ability to raise capital or trade on Nasdaq during the monitoring window.
Investors are closely watching MMTEC’s ability to meet the bid‑price requirement within the one‑year window. The risk of a future suspension of trading or eventual delisting remains high, which could further constrain liquidity and access to capital markets. Management has indicated that it is evaluating options and intends to appeal the delisting determination, but no new guidance on the company’s financial outlook has been issued.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.